Pyrazinamide potential effects on male rats DNA fragmentation, bone type I collagen amino acid composition,

Larysa B Bondarenko1, Ganna M Shayakhmetova, Taisiya F Byshovets

  • 1SI "Institute of Pharmacology & Toxicology", Academy of Medical Sciences of Ukraine, Eugene Potier 14, Kyiv, 03680, Ukraine. larabon04@yahoo.com

Insights

Pyrazinamide, a first-line tuberculosis drug, can negatively impact male rat reproductive health, causing DNA damage and affecting offspring development. These findings highlight potential risks associated with pyrazinamide treatment.

Area of Science:

  • Toxicology
  • Reproductive Biology
  • Molecular Biology

Background:

  • First-line antitubercular agents, including pyrazinamide, are crucial for tuberculosis treatment.
  • Adverse effects of these drugs can lead to treatment failure and necessitate careful monitoring.
  • Understanding the specific toxicological profile of pyrazinamide is essential for optimizing therapeutic strategies.

Purpose of the Study:

  • To evaluate the effects of pyrazinamide on male rat reproductive parameters.
  • To assess pyrazinamide's impact on DNA fragmentation in reproductive organs.
  • To investigate the consequences of pyrazinamide exposure on bone type I collagen and reproductive outcomes in offspring.

Main Methods:

  • Wistar albino male rats were administered pyrazinamide at 1000 mg/kg or 2000 mg/kg daily for 60 days.
  • Bone type I collagen amino acid composition was analyzed using an amino acid analyzer.
  • Testis and epididymis DNA fragmentation was assessed via electrophoresis, and reproductive capability was evaluated through mating and subsequent offspring development analysis.

Main Results:

  • Pyrazinamide administration resulted in dose-dependent quantitative and qualitative changes in male rat reproductive organ DNA and bone type I collagen.
  • Significant alterations in nucleic acid and protein structures were observed compared to control groups.
  • These molecular changes correlated with impaired fertilization, reduced embryogenesis, and decreased posterity survival rates.

Conclusions:

  • Pyrazinamide exposure induces significant reproductive toxicity in male rats.
  • The observed DNA fragmentation and collagen alterations may underlie the impaired reproductive capability and adverse effects on offspring.
  • These findings underscore the importance of considering pyrazinamide's reproductive risks in treatment protocols.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Nondisjunction01:21

Nondisjunction

Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold sister...